Opendata, web and dolomites

M6AQuantKit SIGNED

Development and commercialization of kit for quantitative interrogation of a key RNA modification

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 M6AQuantKit project word cloud

Explore the words cloud of the M6AQuantKit project. It provides you a very rough idea of what is the project "M6AQuantKit" about.

quantitative    patient    labs    glioblastoma    therapeutic    industries    therapeutics    carcinoma    industry    n6    methodology    commercializable    startup    consequently    streamlined    seq    pharma    leukemia    ribonuclease    m6a    ip    multiplexed    market    cancers    commercialization    first    implicated    unmet    self    methyladenosine    quantifying    interrogating    machinery    exhibits    metastasis    kit    harnesses    coupled    input    material    metabolism    poc    diseases    protocol    dysregulation    consistently    vast    mazter    multiple    tool    data    sensitive    samples    interrogation    methylation    levels    stem    prioritizing    position    actions    erc    unravelling    profiling    create    relying    functions    scientific    drug    readout    human    planning    monitoring    amounts    biotech    considerations    rna    renewal    feedback    simultaneous    benefit    immense    rnase    raised    variety    plays    added    representing    seeking    systematic    community    disease    diagnostic    regulation    cancer    roles    amenable    strategy    academic    cell    hepatocellular    fundamental    business   

Project "M6AQuantKit" data sheet

The following table provides information about the project.

Coordinator
WEIZMANN INSTITUTE OF SCIENCE 

Organization address
address: HERZL STREET 234
city: REHOVOT
postcode: 7610001
website: www.weizmann.ac.il

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Total cost 0 €
 EC max contribution 150˙000 € (0%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2019-PoC
 Funding Scheme ERC-POC-LS
 Starting year 2020
 Duration (year-month-day) from 2020-02-01   to  2021-07-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    WEIZMANN INSTITUTE OF SCIENCE IL (REHOVOT) coordinator 150˙000.00

Map

 Project objective

N6-Methyladenosine (m6A) plays fundamental roles in regulation of metabolism, stem cell self-renewal, and metastasis. Consistently its dysregulation is implicated in a variety of human cancers including leukemia, glioblastoma and hepatocellular carcinoma. Consequently, the potential of m6A both as a novel cancer diagnostic and as a drug target has raised immense interest in scientific community and industry. For unravelling m6A functions, for the development of therapeutics and for prioritizing diseases and disease states most likely to benefit from therapeutic targeting of the methylation complex, it is thus of crucial importance to be able to measure the levels at which m6A is present. In our ERC project we addressed this challenge and developed MAZTER-seq, a methodology for quantifying m6A levels relying on a methylation-sensitive ribonuclease (RNase), representing the first systematic approach for quantitative interrogating of m6A levels.

The goal of the project is to advance our approach as commercializable kit for quantitative profiling of m6A. In the PoC, we will develop multiplexed protocol of MAZTER-seq that allows the simultaneous processing and interrogation of multiple samples from low amounts of sample material. The kit, coupled with streamlined data analysis tool, addresses a major market need and exhibits significant added value for academic labs and the biotech & pharma industries targeting the methylation machinery, e.g. for creating novel RNA based therapeutics. Our readout from low-input material makes m6A monitoring amenable to patient samples, representing an unmet challenge across all our target market. Thus, our goal is to create a startup which harnesses the vast market potential. In the PoC, the commercialization considerations are advanced through actions such as, seeking market feedback, strengthening the IP position, defining the business strategy and planning business execution.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "M6AQUANTKIT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "M6AQUANTKIT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

SUExp (2018)

Strategic Uncertainty: An Experimental Investigation

Read More  

InsideChromatin (2019)

Towards Realistic Modelling of Nucleosome Organization Inside Functional Chromatin Domains

Read More  

DYMOLAMO (2018)

Dynamic Modeling of Labor Market Mobility and Human Capital Accumulation

Read More  
lastchecktime (2022-11-27 6:06:30) correctly updated